FIELD: medicine.
SUBSTANCE: invention represents a biodegradable haemostatic therapeutic agent for bleeding. Using the prepared haemostatic agent according to the declared method provides a rate of control of bleeding making 45±2 seconds.
EFFECT: higher rate of control of bleeding.
4 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
BIODEGRADABLE HAEMOSTATIC THERAPEUTIC AGENT | 2013 |
|
RU2522980C1 |
TEXTILE MATERIAL FOR HAEMOSTASIS AND METHOD FOR MAKING THEREOF | 2007 |
|
RU2380117C2 |
METHOD OF OBTAINING DISPOSABLE ATRAUMATIC APPLICATION | 2009 |
|
RU2448738C2 |
HEMOSTATIC COATING IN THE FORM OF POWDER | 2017 |
|
RU2660582C1 |
METHOD FOR PRODUCING EX VIVO SOLUBLE FIBRINOGEN | 2014 |
|
RU2571288C1 |
METHOD OF INCREASING REACTIVITY OF LEVAN AND FORMING PROTEIN-POLYSACCHARIDE FILMS | 2022 |
|
RU2813119C1 |
HEMOSTATIC COMPOSITIONS AND METHODS FOR THEIR PREPARATION | 2017 |
|
RU2756891C2 |
HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
HEMOSTATIC SOLUTION BASED ON SULFUSATED POLYSACCHARIDES AND THE HEMOSTATIC SPONGES PRODUCTION FROM THIS SOLUTION (OPTIONS) | 2017 |
|
RU2652270C1 |
Authors
Dates
2014-07-20—Published
2013-04-23—Filed